Adults 18 to 70, any sex, with Incomplete Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Corticospinal ExcitabilityPrimary· We will measure TMS before the start of 5 consecutive days of AIH or SHAM treatment. We will measure TMS within 24 hours of the final treatment.
Transcranial magnetic stimulation (TMS) can be applied over the primary motor cortex to examine changes in corticospinal excitability. The downstream muscle activation can be recorded with surface EMG as a motor-evoked potential (MEP). The peak-to-peak MEP amplitude (mV) is as an index of corticospinal excitability.
A randomized sequence of TMS intensities can be applied over the primary motor cortex, ranging from 90-140% of the participants' resting motor threshold (RMT). The mean MEP amplitude will be plotted against the corresponding stimulation intensity to produce the recruitment curve.
Group
Value
95% CI
Repetitive Acute Intermittent Hypoxia
0.528
± 0.188
SHAM Acute Intermittent Hypoxia
0.132
± 0.188
Step Length AsymmetryPrimary· We will compare asymmetry 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).
Step length asymmetry will be quantified as the ratio of the normalized difference in step lengths between the fast and slow legs during split-belt motor adaptation: (Fast leg - Slow leg step length) / (Fast leg + Slow leg step length).
Group
Value
95% CI
Repetitive Acute Intermittent Hypoxia
-0.052
± 0.023
Control Group
-0.0478
± 0.024
Step Time AsymmetryPrimary· We will compare asymmetry 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).
Step time asymmetry will be quantified as the ratio of the normalized difference in step times between the fast and slow legs during split-belt motor adaptation: (Fast leg - Slow leg step time) / (Fast leg + Slow leg step time).
Group
Value
95% CI
Repetitive Acute Intermittent Hypoxia
0.0781
± 0.021
Control Group
0.0681
± 0.0252
Net Metabolic PowerPrimary· We will compare net metabolic power 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).
Using expired gas analyses, we will calculate net metabolic power by inputting steady-state values for V̇O₂ and V̇CO₂ into standard regression equations (W), subtracting resting values, and normalizing the result to each participant's body weight (kg).
Group
Value
95% CI
Repetitive Acute Intermittent Hypoxia
3.87
± 0.397
Control Group
4.27
± 0.766
Sponsor's own description
The goal of this study is to examine the effect of repetitive acute intermittent hypoxia on motor learning abilities in able-bodied individuals for subsequent study in individuals with incomplete spinal cord injury.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
NCT05848778 — Non-invasive Therapy to Drive Nerve Regeneration
· NA
· enrolling by invitation
NCT05164705 — Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia
· NA
· completed
NCT04890639 — Acute Intermittent Hypoxia in Traumatic Brain Injury
· NA
· completed
NCT03957213 — Enhancing Cognition in Older Adults With Intermittent Hypoxia and Cognitive Training
· NA
· completed
NCT05183113 — Measuring the Neurological Benefits of Intermittent Hypoxia Therapy With MRI
· NA
· completed
Other recruiting trials for Incomplete Spinal Cord Injury
Currently open trials in the same condition.
NCT07237386 — Comparing the Ceriter Stride One, a Pressure-sensitive Smart Insole, With Gait Parameters Measured on the GRAIL in Neuro
· NA
· recruiting
NCT07135583 — Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
· NA
· recruiting
NCT05726591 — Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Dis
· NA
· recruiting
NCT05491837 — Effects of Intermittent Hypoxia in Upper and Lower Limb Functions in Persons With Incomplete Spinal Cord Injury
· NA
· recruiting
NCT04809987 — Effectiveness of Virtual Gait System Intervention in Motor Function in People with Incomplete Spinal Cord Injury.
· NA
· active not recruiting
Other University of Colorado, Boulder trials
Trials by the same sponsor.
NCT07527338 — Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use
· Phase 2, PHASE3
· not yet recruiting
NCT07011160 — Neural Substrates Underlying Adaptations in Manual Dexterity of Older Adults
· NA
· not yet recruiting
NCT07127965 — Exercise Adherence and Cognitive Decline: Phase 2
· NA
· recruiting
NCT06588582 — Perceptual Influences From Smoking Cannabis: an Experimental Study
· NA
· recruiting
NCT06769022 — Exercise Adherence and Cognitive Decline
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Boulder
Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05341466.